Apo-Sumatriptan 50 mg (Sumatriptan (Sumatriptan Succinate) TABLET) 50 MG

APO-SUMATRIPTAN 50 MG tablets contain sumatriptan succinate, a medication used for migraine relief. This oral treatment is designed to alleviate headache pain and associated symptoms.

Strength

50 MG

Pack Size

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-SUMATRIPTAN 50 MG is commonly used for the acute treatment of migraines with or without aura in adults. It is not intended for preventive use but rather to address migraine attacks once they begin. Sumatriptan works by narrowing blood vessels around the brain, which can help reduce the severity and duration of migraine pain.

Side Effects

When taken as directed, APO-SUMATRIPTAN 50 MG may help relieve migraine headache pain, nausea, and sensitivity to light or sound. Some users report feeling relief within a few hours of taking the medication. However, individual responses can vary.

Precautions & Warnings

APO-SUMATRIPTAN 50 MG should be used with caution in individuals with a history of heart disease, high blood pressure, or liver problems. It is important to follow the advice of a healthcare provider regarding its use, especially if you have other medical conditions or are taking other medications.

Avoid Interactions

Sumatriptan may interact with certain medications, including other migraine treatments, antidepressants, and drugs that affect blood pressure. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

APO-SUMATRIPTAN 50 MG is used for the acute treatment of migraines with or without aura in adults.

APO-SUMATRIPTAN 50 MG is taken orally, typically at the first sign of a migraine. Follow the instructions provided by your healthcare provider.

Common side effects may include dizziness, nausea, and fatigue. Individual experiences can vary.

No, APO-SUMATRIPTAN 50 MG is not intended for preventive use. It is designed to treat migraine attacks once they begin.

APO-SUMATRIPTAN 50 MG should be used with caution in individuals with certain medical conditions. Consult a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.